醫療新知 > 能檢測乳癌的 itBra

能檢測乳癌的 itBra






A new technology that could revolutionize breast cancer screening is about to begin clinical trials in the Bay Area. Rather than a mammogram or ultrasound, this system can be used at home, with potentially life-saving information transmitted through a smartphone.

For Dian Gaxiola, a routine breast screening at El Camino Hospital in Mountain View turned out to be a lifesaver. Doctors caught her cancer at a very early stage and saved her breast.

"I was very lucky, I think because of the early detection," cancer survivor Dian Gaxiola said. 

El Camino Hospital Radiologist Dr. Sila Yitta says routine mammograms and self-screening are the best defense, although many women don't always take advantage. 

"In my experience it is hit or miss, I think women, some women are consistent in doing breast exams at home, some women don't do them at all, and I often times get questions from women, asking simply, 'How do I do an exam,'" Yitta said. 

However soon, an experimental technology could help thousands of women and doctors screen for breast cancer in a new way. It's called the iTBra.

"So you'll be putting that on, so it'll now be centered over you,"

Cyrcadia Health CEO Rob Royea says the patches can be worn inside any normal bra. He said, "It's a wearable device with a number of sensors that check what happens with your circadian patterns of heat change on your breast over time."

Roye says the heat changes correlate to the accelerated cell activity associated with breast tumors. The results are then processed using sophisticated algorithms and transmitted to a smartphone.

"You wear the device for a few hours, and that information is automatically communicated to your physician," Rob Royea, Cyrcadia Health

Because the system is heat based, developers believe it may also offer advantages for some women with denser breast tissue, which can be more difficult to image using traditional mammography.

"We believe we're tissue agnostic. Meaning that for all tissues we react about the same," Rob Royea from Cyrcadia Health said.

The clinical trial being conducted at El Camino Hospital will study the results on women wearing the device for different lengths of time. The goal is to produce accurate readings in roughly two hours, ultimately making the system more convenient for women to use.

"An ideal breast cancer screening test would catch the cancer when it's smaller and easier to treat," Sila Yitta, M.D., from El Camino Hospital said. 

And whether it's a routine mammogram, or at home screening, cancer survivor Dian Gaxiola believes any investment in early detection, is worth the time.

"It's very valuable," cancer survivor Fulldian Gaxioloa said. 

If the trial is successful, Cyrcadia Health hopes to have the iTBra on the market later this year.

Written and produced by Tim Didion









一家名為Cyrcadia Health的新企業就開發了名為iTbra的胸圍,它內部搭載了數個溫度探測器,並且可以配合一個程式來檢測佩戴者的乳房健康程度。該公司表示,這個產品的檢測速度比乳房X光更快,而且能夠提供更加準確的乳腺組織掃描結果。該公司CEO Rob Royea表示,截止到2016年,他們計劃在美國取得FDA認證,讓醫生用這種設備來代替傳統的乳房X光。




中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌 2022年8月8日 1 中大醫學院領導的一項多中心臨床研究發現 […]
新藥Dostarlimab給MMR缺損病人的新希望 [醫療新資訊] MMR缺損對人們有甚麼影響呢﹖為甚麼新藥D […]
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎 ▲ 左起:病理解剖及細胞學系助理教授鄧銘 […]
芯片上的蠕蟲能視作癌症偵察器﹖ [癌症資訊新聞] 根據《科學報告》學術期刊發表了一篇研究報告指,科學家利用秀麗 […]
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者   在眾多癌 […]
(重磅新聞) ASCO2021值得關注的臨床腫瘤學科研成果
ASCO2021值得關注的臨床腫瘤學科研成果 [醫藥新聞] 美國臨床腫瘤學會(ASCO)代表所有關心癌症患者的 […]
港大醫學院發現肝癌細胞耐藥性及腫瘤復發的新分子機制 2021年06月01日 港大醫學院發現肝癌細胞耐藥性及腫瘤 […]